跳至主要内容
临床试验/JPRN-jRCTs061230094
JPRN-jRCTs061230094尚未招募Unknown

A clinical study to evaluate the effect of dantrolene sodium hydrate on kidney function and albuminuria in patients with moderately to severely reduced kidney function

chinoumi Hitoshi0 个研究点目标入组 15 人开始时间: 2024年1月29日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Chronic Kidney Disease (CKD) patients who receive treatment according Evidence-based Clinical Practice Guideline for CKD 2018.
  • 2. Female or male aged >=20 years at the time of consent
  • 3. eGFR >=25 and <=45 mL/min/1.73m2 at visit 0 or UACR >=200 and <=5000 mg/gCr at visit 0
  • 4. Provision of signed informed consent prior to any study specific procedures
  • 5. Out-patient of Yamaguchi university hospital

排除标准

  • 1) Patient who should receive therapy with immune suppressive drugs (e.g. prednisolone >= 5 mg/day or equivalent) who primary investigator and investigators consider as unstable condition of the disease.
  • 2) History of receiving therapy with immune suppressive drugs (e.g. prednisolone >= 5 mg/day or equivalent) within 3 months of obtaining informed consent
  • 3) UPCR (urinary protein-to-creatinine ratio: g/gCr) measured from spot urine sample >= 3.0 at screening period
  • 4) Acute renal failure
  • 5) Drug-induced renal dysfunction
  • 6) Continuously receiving hemodialysis and peritoneal dialysis or is planned to receive these renal replacement therapy
  • 7) History of renal transplantation, or is planned to receive this surgery during the present study
  • 8) Uncontrollable diabetes mellitus, hypertension or hyperthyroidism
  • 9) Receiving therapy with acute heart failure or lethal arrhythmia
  • 10) COPD and severe respiratory dysfunction
  • 11) Diagnosed with myasthenia graves
  • 12) Severe liver dysfunction
  • 14) Patient who could not receive oral medication
  • 15) History of allergy and hypersensitivity for dantrolene
  • 16) Pregnant or potentially pregnant women or breastfeeding
  • 17) History of acute coronary syndrome, stroke, transient ischemic attack within 3 months prior to obtaining informed consent
  • 18) Cardiac, carotid, or other major CV surgery (surgical/transcatheter) was performed within 3 months of obtaining informed consent or is planned to receive these surgery within the 3 months after obtaining informed consent
  • 19) Severe inflammatory disease such as sepsis and pneumonia etc.
  • 20) Active cancer
  • 21) Patient who primary investigator and investigators consider as unsuitable for the present study

研究者

发起方
chinoumi Hitoshi

相似试验